Genomic Profiling of Circulating Tumor DNA Predicts Outcome and Demonstrates Tumor Evolution in ALK-Positive Non-Small Cell Lung Cancer Patients

With the rapid development of targeted therapies for the treatment of cancer, methods for predicting response and outcome are in high demand. Non-small cell lung cancer driven by genomic rearrangements of the anaplastic lymphoma kinase (ALK) gene can be successfully treated with ALK-targeted therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Madsen, Anne Tranberg, Winther-Larsen, Anne, McCulloch, Tine, Meldgaard, Peter, Sorensen, Boe Sandahl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226192/
https://www.ncbi.nlm.nih.gov/pubmed/32290439
http://dx.doi.org/10.3390/cancers12040947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226192/
https://www.ncbi.nlm.nih.gov/pubmed/32290439
http://dx.doi.org/10.3390/cancers12040947

Ejemplares similares